Which has grown faster, AKBA or CGEN?

Over the past five years, CGEN grew revenue faster — AKBA at a -0.26% CAGR versus CGEN at 105.91%.

Is AKBA or CGEN more profitable?

CGEN runs the higher net margin — AKBA at -13.54% versus CGEN at 47.55%.

How have AKBA and CGEN total returns compared?

Over the past 10 years, AKBA delivered -20.53% and CGEN delivered -9.42% annualized total return. Past performance doesn't predict future results.

Akebia Therapeutics, Inc. (AKBA) vs Compugen Ltd. (CGEN)

A side-by-side comparison of Akebia Therapeutics, Inc. and Compugen Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AKBA

Akebia Therapeutics, Inc.

$244M

$0.91HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

CGEN

Compugen Ltd.

$218M

$2.31HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — AKBA vs CGEN

growth of $100 · dividends reinvested · last 10y

AKBA -89.7% (-20.4%/yr)CGEN -63.7% (-9.6%/yr)CGEN compounded faster over this window

AKBA CGEN

AKBA vs CGEN: by the numbers

•AKBA is the larger company ($244M vs $218M market cap).
•CGEN is profitable (47.55% net margin) while AKBA runs a net loss (-13.54%).
•CGEN grew revenue faster over the past five years (105.91% vs -0.26% CAGR).

Metrics side by side

Valuation

Metric	AKBA	CGEN
P/E ratio	N/A	6.15
P/S ratio	1.11	2.95
P/B ratio	9.76	2.46
FCF yield	16.45%	N/A

Profitability

Metric	AKBA	CGEN
Gross margin	79.48%	86.89%
Operating margin	9.95%	40.94%
Net margin	-13.54%	47.55%
ROE	-118.58%	39.66%
ROIC	-7.08%	26.14%

Growth (annualized)

Metric	AKBA	CGEN
Revenue CAGR (5Y)	-0.26%	105.91%
Total return CAGR (5Y)	-20.07%	-18.39%

Frequently asked

Which has grown faster, AKBA or CGEN?: Over the past five years, CGEN grew revenue faster — AKBA at a -0.26% CAGR versus CGEN at 105.91%.
Is AKBA or CGEN more profitable?: CGEN runs the higher net margin — AKBA at -13.54% versus CGEN at 47.55%.
How have AKBA and CGEN total returns compared?: Over the past 10 years, AKBA delivered -20.53% and CGEN delivered -9.42% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AKBA analysis Full CGEN analysis Interactive comparison tool

Dig into the metrics

Compugen P/E ratio Akebia Therapeutics ROE Compugen ROE Akebia Therapeutics operating margin Compugen operating margin Akebia Therapeutics revenue growth Compugen revenue growth Akebia Therapeutics free cash flow Compugen free cash flow

Akebia Therapeutics & Compugen appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.